Researchers
- IWASA Tsutomu
- Lecturer
| Faculty | Department of Medicine |
|---|---|
| Researchmap | https://researchmap.jp/iwasa_t |
Education and Career
Education
- 1997/04 - 2003/03 , Kindai University, Faculty of Medicine,
- 2005/04 - 2008/03 , Kindai University, Faculty of Medicine, Graduate school of Medical science, Department of Medical Oncology,
Academic & Professional Experience
- Apr. 2014 - Today , Kindai University, Faculty of Medicine Department of Medical Oncology Lucture
- Sep. 2012 - Mar. 2014 , Kindai University, Faculty of Medicine Department of Medical Oncology Assistant professor
- Jul. 2010 - Aug. 2012 , Dana-Farber Cancer Institute Posdoc fellow
- May. 2010 - Jun. 2010 , Kindai University, Faculty of Medicine Department of Medical Oncology Assistant professor
- Apr. 2009 - Apr. 2010 , National Hospital Organization Minami Wakayama Medical Center Department of respiratory medicine Staff
- Apr. 2003 - Mar. 2008 , Kindai University, Faculty of Medicine Department of Medical Oncology Assistant Professor
Research Activities
Research Areas
- Life sciences, Genomics
- Life sciences, Tumor diagnostics and therapeutics
- Life sciences, Tumor biology
- Life sciences, Internal medicine - General
Published Papers
-
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade
Hidetoshi Hayashi; Kenji Chamoto; Ryusuke Hatae; Takashi Kurosaki; Yosuke Togashi; Kazuya Fukuoka; Megumi Goto; Yasutaka Chiba; Shuta Tomida; Takayo Ota; Koji Haratani; Takayuki Takahama; Junko Tanizaki; Takeshi Yoshida; Tsutomu Iwasa; Kaoru Tanaka; Masayuki Takeda; Tomoko Hirano; Hironori Yoshida; Hiroaki Ozasa; Yuichi Sakamori; Kazuko Sakai; Keiko Higuchi; Hitoshi Uga; Chihiro Suminaka; Toyohiro Hirai; Kazuto Nishio; Kazuhiko Nakagawa; Tasuku Honjo
Journal of Clinical Investigation 134 (7) 1, Apr. 2024 -
治療前CD163はニボルマブ+化学療法における予後不良因子(WJOG9917BTR)
尾崎 由記範; 岩朝 勤; 北野 滋久; 山下 万貴子; 鶴谷 純司; 高橋 將人; 向原 徹; 増田 慎三; 二村 学; 南 博信; 松本 光史; 田辺 裕子; 川端 英孝; 吉村 健一; 高野 利実
日本癌治療学会学術集会抄録集 61回 , O25-3, Oct. 2023 -
Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B).
Hiroko Masuda; Yuko Tanabe; Hitomi Sakai; Koji Matsumoto; Akihiko Shimomura; Mihoko Doi; Yasuo Miyoshi; Masato Takahashi; Yasuaki Sagara; Shinya Tokunaga; Tsutomu Iwasa; Naoki Niikura; Kenichi Yoshimura; Toshimi Takano; Junji Tsurutani
Breast (Edinburgh, Scotland) 71 , 22-28, Oct. 2023
Conference Activities & Talks
- Retrospective study of chemotherapy for elderly patients for breast cancer , Tsutomu Iwasa , 2018 Japanese Society of Medical Oncology Annual Meeting , 20, Jul. 2018
- Phase II trial of Eribulin and S-1 combination therapy for advanced or recurrent breast cancer , Tsutomu Iwasa , ESMO ASIA 2017 , 18, Nov. 2017
- Retrospective analysis of 74 breast cancer patients with Eribulin treatment , Tsutomu Iwasa , 2017 Japanese Society of Medical Oncology Annual Meetinng , 27, Jul. 2017
MISC
- ニボルマブ+イピリムマブ併用療法中に敗血症との鑑別を要する免疫関連下垂体炎を発症した肺腺癌の1例 , 村田修一; 谷崎潤子; 岩朝勤; 黒崎隆; 田中薫; 林秀敏; 中川和彦; 濱有一郎 , 肺癌(Web) , 63 , 3 , 2023
- Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR+, HER2-metastatic breast cancer: WJOG11418B NEWFLAME trial , Jun Masuda; Junji Tsurutani; Norikazu Masuda; Yuko Tanabe; Tsutomu Iwasa; Masato Takahashi; Manabu Futamura; Koji Matsumoto; Kenjiro Aogi; Hiroji Iwata; Mari Hosonaga; Toru Mukohara; Kenichi Yoshimura; Toshimi Takano , CANCER RESEARCH , 81 , 4 , Feb. 2021
- Immunological analysis of the combination therapy of nivolumab, paclitaxel and bevacizumab in patients with HER2negative MBC in NEWBEAT trial (WJOG9917BTR) , Yukinori Ozaki; Shigehisa Kitano; Junji Tsurutani; Tsutomu Iwasa; Masato Takahashi; Toru Mukohara; Norikazu Masuda; Manabu Futamura; Hironobu Minami; Koji Matsumoto; Hidetaka Kawabata; Makiko Yamashita; Kenichi Yoshimura; Toshimi Takano , CANCER RESEARCH , 81 , 4 , Feb. 2021